Batas Pemasukan Perubahan Tanggal
AbbVie USD 695M 1.12B 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Cytokinetics USD -206.03M 23M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
J&J USD 5.24B 119M 2026-03
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Merck USD -4.24B 7.2B 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Xencor USD -128.92M 122.26M 2026-03